Plant-based Biologics Market Growth Accelerated by Adoption of Green and Sustainable Manufacturing Processes

 The plant-based biologics market involves innovative and sustainable biomanufacturing technologies for producing biotherapeutics such as monoclonal antibodies, recombinant proteins, and vaccines using plant-based expression platforms. These technologies provide scalable and cost-effective production solutions as compared to traditional cell culture and fermentation methods. Plant-based platforms offer several advantages like rapid scalability, lack of pathogens, better yields, and human-compatible post-translational modifications. With growing awareness about environmental sustainability, more pharmaceutical companies are adopting green manufacturing practices like plant-based biologics.

The global plant-based biologics market is estimated to be valued at US$ 19.4 Mn in 2024 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the major trends driving the growth of the plant-based biologics market is the increasing preference for sustainable and environment-friendly production practices. Conventional mammalian cell culture and microbial fermentation methods require large amounts of water, energy and generate significant carbon emissions. On the other hand, plant-based systems do not require costly infrastructure and have a significantly lower environmental footprint. For instance, biomanufacturing in plants does not generate toxic by-products that need expensive treatment before disposal. With growing climate change concerns, sustainability is gaining importance among pharmaceutical companies and driving adoption of green bioproduction technologies like plant-made therapeutics. This trend is expected to continue boosting demand for plant-based biologics during the forecast period.

Segment Analysis
The global plant-based biologics market is segmented on the basis of product type and application. By product type, the vaccines segment dominates the market. Vaccines produced from plant platforms have gained increasing importance due to their ability to induce a stronger immune response as compared to traditionally produced vaccines. This is attributed to the lower production cost of plant-made vaccines along with their ability to induce protective immunity against various pathogens including influenza, HPV, cholera, and others. By application, the therapeutic area segment accounts for the largest share of the market. Increasing incidence of chronic diseases along with growing demand for cost-effective treatment options is fueling the demand for plant-based therapeutic proteins for conditions like diabetes, hemophilia, and others.

Key Takeaways

The global plant-based biologics market is expected to witness high growth over the forecast period driven by advantages over conventional biomanufacturing and growing biologics demand.
 
Regional analysis shows that North America dominates the global plant-based biologics market with the largest share. This is attributed to well-established pharmaceutical industry, high healthcare spending, and rapid adoption of advanced technologies in the region. Key players are focusing on expansion of manufacturing facilities and collaboration with research institutes in the region to cater to the growing demand.

Key players operating in the plant-based biologics market are Leaf Expression Systems, Zea Biosciences, Planet Biotechnology Inc., InVitria, PlantForm Corporation, IBIO, Inc., Mapp Biopharmaceutical, Inc., Pfizer Inc., Ventria Bioscience Inc., Medicago Inc., Eleva GmbH, Kentucky Bioprocessing, LLC, Solarvest Bioenergy Inc., and Byondis B.V. Most leading players are focusing on enhancing their production capabilities through facility expansion. They are also investing in R&D activities to develop new plant-based biologics to expand their product portfolios. Partnerships and licensing agreements are among the key strategies adopted by players to strengthen their market position.